6 | plasma albumin level | F344/NSlc | male | 0.39 | g/l | fasting (for 16 hours) | 77467 | fasting (for 16 hours) | | |

7 | serum insulin level | F344/NSlc | male | 0.000222 | mg/dl | specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) | 67475 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | glucose solution, 2.8M (2 g/kg) |

9 | serum insulin level | F344/NSlc | male | 0.000301 | mg/dl | fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) | 66176 | fasting (between 16 and 18 hours) | glucose solution, 2.8M (2 g/kg) | |

7 | serum free fatty acids level | F344/NSlc | male | 0.67 | mmol/l | specific pathogen-free condition (for 210 days) then fasting (for 1 days) | 67495 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | |

9 | serum free fatty acids level | F344/NSlc | male | 0.64 | mmol/l | fasting | 66184 | fasting | | |

6 | plasma triglyceride level | F344/NSlc | male | 1.4125 | mmol/l | fasting (for 16 hours) | 77473 | fasting (for 16 hours) | | |

7 | epididymal fat pad weight to body weight ratio | F344/NSlc | male | 3.01 | % | naive control condition | 98072 | naive control condition | | |

5 | epididymal fat pad weight to body weight ratio | F344/NSlc | male | 2.7 | % | naive control condition | 97742 | naive control condition | | |

7 | epididymal fat pad weight to body weight ratio | F344/NSlc | male | 2.63 | % | specific pathogen-free condition (for 210 days) then fasting (for 1 days) | 67491 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | |

9 | epididymal fat pad weight to body weight ratio | F344/NSlc | male | 2.62 | % | naive control condition | 66196 | naive control condition | | |

6 | blood hemoglobin level | F344/NSlc | male | 17 | g/dl | fasting (for 16 hours) | 77454 | fasting (for 16 hours) | | |

7 | retroperitoneal fat pad weight to body weight ratio | F344/NSlc | male | 2.87 | % | naive control condition | 98067 | naive control condition | | |

5 | retroperitoneal fat pad weight to body weight ratio | F344/NSlc | male | 2.4 | % | naive control condition | 97734 | naive control condition | | |

7 | retroperitoneal fat pad weight to body weight ratio | F344/NSlc | male | 2.19 | % | specific pathogen-free condition (for 210 days) then fasting (for 1 days) | 67471 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | |

9 | retroperitoneal fat pad weight to body weight ratio | F344/NSlc | male | 2.65 | % | naive control condition | 66194 | naive control condition | | |

6 | lung wet weight | F344/NSlc | male | 0.848 | g | specific pathogen-free condition | 71829 | specific pathogen-free condition | | |

6 | spleen weight to body weight ratio | F344/NSlc | male | 0.219 | % | specific pathogen-free condition | 71838 | specific pathogen-free condition | | |

6 | mean corpuscular volume | F344/NSlc | male | 54.6 | fl | fasting (for 16 hours) | 77456 | fasting (for 16 hours) | | |

6 | body temperature | F344/NSlc | male | 37.9 | degrees C | specific pathogen-free condition | 74987 | specific pathogen-free condition | | |

6 | both kidneys wet weight as percentage of body weight | F344/NSlc | male | 0.612 | % | specific pathogen-free condition | 71834 | specific pathogen-free condition | | |

7 | retroperitoneal fat pad weight | F344/NSlc | male | 12.6 | g | naive control condition | 98056 | naive control condition | | |

5 | retroperitoneal fat pad weight | F344/NSlc | male | 9.35 | g | naive control condition | 97722 | naive control condition | | |

7 | retroperitoneal fat pad weight | F344/NSlc | male | 8.7 | g | specific pathogen-free condition (for 210 days) then fasting (for 1 days) | 12781 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | |

9 | retroperitoneal fat pad weight | F344/NSlc | male | 10.3 | g | naive control condition | 66188 | naive control condition | | |

6 | hematocrit | F344/NSlc | male | 51.9 | % | fasting (for 16 hours) | 77455 | fasting (for 16 hours) | | |

7 | blood glucose level | F344/NSlc | male | 78 | mg/dl | specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) | 12770 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | glucose solution, 2.8M (2 g/kg) |

7 | blood glucose level | F344/NSlc | male | 149 | mg/dl | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13160 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |

7 | blood glucose level | F344/NSlc | male | 157 | mg/dl | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13159 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |

7 | blood glucose level | F344/NSlc | male | 149.1 | mg/dl | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13158 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |

7 | blood glucose level | F344/NSlc | male | 134.1 | mg/dl | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13157 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |

7 | blood glucose level | F344/NSlc | male | 99 | mg/dl | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 13156 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |

22 | blood glucose level | F344/NSlc | male | 107.3 | mg/dl | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 13210 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) | |

22 | blood glucose level | F344/NSlc | male | 106 | mg/dl | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 13209 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) | |

22 | blood glucose level | F344/NSlc | male | 112 | mg/dl | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 13208 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) | |

22 | blood glucose level | F344/NSlc | male | 105.6 | mg/dl | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 13207 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) | |

22 | blood glucose level | F344/NSlc | male | 87 | mg/dl | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 13206 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) | |

6 | brain weight to body weight ratio | F344/NSlc | male | 0.843 | % | specific pathogen-free condition | 71826 | specific pathogen-free condition | | |

6 | liver weight as percentage of body weight | F344/NSlc | male | 3.063 | % | specific pathogen-free condition | 71832 | specific pathogen-free condition | | |

7 | serum triglyceride level | F344/NSlc | male | 130.17 | mg/dl | naive control condition | 97750 | naive control condition | | |

7 | serum triglyceride level | F344/NSlc | male | 108.4 | mg/dl | specific pathogen-free condition (for 210 days) then fasting (for 1 days) | 13192 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | |

9 | serum triglyceride level | F344/NSlc | male | 122.4 | mg/dl | naive control condition | 66182 | naive control condition | | |

7 | mesenteric fat pad weight | F344/NSlc | male | 11.44 | g | naive control condition | 98051 | naive control condition | | |

10 | mesenteric fat pad weight | F344/NSlc | male | 7.67 | g | naive control condition | 97726 | naive control condition | | |

7 | mesenteric fat pad weight | F344/NSlc | male | 7 | g | specific pathogen-free condition (for 210 days) then fasting (for 1 days) | 12780 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | |

9 | mesenteric fat pad weight | F344/NSlc | male | 8.9 | g | naive control condition | 66186 | naive control condition | | |

7 | serum total cholesterol level | F344/NSlc | male | 45.77 | mg/dl | naive control condition | 97746 | naive control condition | | |

7 | serum total cholesterol level | F344/NSlc | male | 69.7 | mg/dl | specific pathogen-free condition (for 210 days) then fasting (for 1 days) | 12775 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | |

9 | serum total cholesterol level | F344/NSlc | male | 52.4 | mg/dl | naive control condition | 66180 | naive control condition | | |

6 | systolic blood pressure | F344/NSlc | male | 149 | mmHg | specific pathogen-free condition | 74985 | specific pathogen-free condition | | |

6 | lung weight to body weight ratio | F344/NSlc | male | 0.391 | % | specific pathogen-free condition | 71830 | specific pathogen-free condition | | |

6 | liver wet weight | F344/NSlc | male | 6.647 | g | specific pathogen-free condition | 71831 | specific pathogen-free condition | | |

6 | plasma creatinine level | F344/NSlc | male | 0.24 | mg/dl | fasting (for 16 hours) | 77476 | fasting (for 16 hours) | | |

6 | plasma total cholesterol level | F344/NSlc | male | 53 | mg/dl | fasting (for 16 hours) | 77470 | fasting (for 16 hours) | | |

6 | both adrenal glands wet weight | F344/NSlc | male | 45.7 | mg | specific pathogen-free condition | 71835 | specific pathogen-free condition | | |

6 | plasma glucose level | F344/NSlc | male | 144 | mg/dl | fasting (for 16 hours) | 77469 | fasting (for 16 hours) | | |

9 | plasma glucose level | F344/NSlc | male | 80 | mg/dl | fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) | 66172 | fasting (between 16 and 18 hours) | glucose solution, 2.8M (2 g/kg) | |

6 | heart rate | F344/NSlc | male | 449 | beats/min | specific pathogen-free condition | 74986 | specific pathogen-free condition | | |

6 | brain wet weight | F344/NSlc | male | 1.829 | g | specific pathogen-free condition | 71825 | specific pathogen-free condition | | |

7 | epididymal fat pad weight | F344/NSlc | male | 13.23 | g | naive control condition | 98059 | naive control condition | | |

5 | epididymal fat pad weight | F344/NSlc | male | 9.79 | g | naive control condition | 97730 | naive control condition | | |

7 | epididymal fat pad weight | F344/NSlc | male | 10.4 | g | specific pathogen-free condition (for 210 days) then fasting (for 1 days) | 12782 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | |

9 | epididymal fat pad weight | F344/NSlc | male | 10.2 | g | naive control condition | 66190 | naive control condition | | |

6 | mean corpuscular hemoglobin concentration | F344/NSlc | male | 32.7 | g/dl | fasting (for 16 hours) | 77458 | fasting (for 16 hours) | | |

6 | heart wet weight | F344/NSlc | male | 0.728 | g | specific pathogen-free condition | 71827 | specific pathogen-free condition | | |

6 | both kidneys wet weight | F344/NSlc | male | 1.329 | g | specific pathogen-free condition | 71833 | specific pathogen-free condition | | |

7 | body weight | F344/NSlc | male | 393.6 | g | specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) | 12785 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | glucose solution, 2.8M (2 g/kg) |

22 | body weight | F344/NSlc | male | 386.4 | g | fasting (for 16 hours) | 11983 | fasting (for 16 hours) | | |

7 | body weight | F344/NSlc | male | 470.3 | g | specific pathogen-free condition then fasting (for 16 hours) | 11607 | specific pathogen-free condition | fasting (for 16 hours) | |

6 | mean corpuscular hemoglobin level | F344/NSlc | male | 17.8 | pg | fasting (for 16 hours) | 77457 | fasting (for 16 hours) | | |

6 | plasma high density lipoprotein cholesterol level | F344/NSlc | male | 33.8 | mg/dl | fasting (for 16 hours) | 77471 | fasting (for 16 hours) | | |

6 | both testes wet weight | F344/NSlc | male | 2.588 | g | specific pathogen-free condition | 71839 | specific pathogen-free condition | | |

6 | plasma low density lipoprotein cholesterol level | F344/NSlc | male | 5 | mg/dl | fasting (for 16 hours) | 77472 | fasting (for 16 hours) | | |

6 | both testes wet weight to body weight ratio | F344/NSlc | male | 1.193 | % | specific pathogen-free condition | 71840 | specific pathogen-free condition | | |

7 | mesenteric fat pad weight to body weight ratio | F344/NSlc | male | 2.6 | % | naive control condition | 98063 | naive control condition | | |

10 | mesenteric fat pad weight to body weight ratio | F344/NSlc | male | 1.9 | % | naive control condition | 97738 | naive control condition | | |

7 | mesenteric fat pad weight to body weight ratio | F344/NSlc | male | 1.77 | % | specific pathogen-free condition (for 210 days) then fasting (for 1 days) | 67467 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | |

9 | mesenteric fat pad weight to body weight ratio | F344/NSlc | male | 2.33 | % | naive control condition | 66192 | naive control condition | | |

6 | spleen wet weight | F344/NSlc | male | 0.475 | g | specific pathogen-free condition | 71837 | specific pathogen-free condition | | |

22 | blood glucose level area under curve (AUC) | F344/NSlc | male | 12619.8 | (mg/dl) x min | fasting (for 16 hours) then glucose solution, 2.8M (2 g/kg) | 67778 | fasting (for 16 hours) | glucose solution, 2.8M (2 g/kg) | |

7 | blood glucose level area under curve (AUC) | F344/NSlc | male | 1.8 | (mg/dl) x min | specific pathogen-free condition then fasting (for 16 hours) then glucose solution (2 g/kg) | 11606 | specific pathogen-free condition | fasting (for 16 hours) | glucose solution (2 g/kg) |

9 | blood glucose level area under curve (AUC) | F344/NSlc | male | 12200 | (mg/dl) x min | fasting (between 16 and 18 hours) then glucose solution, 2.8M (2 g/kg) | 66174 | fasting (between 16 and 18 hours) | glucose solution, 2.8M (2 g/kg) | |

7 | serum adiponectin level | F344/NSlc | male | 3.28 | ng/ml | specific pathogen-free condition (for 210 days) then fasting (for 1 days) | 67479 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | |

7 | serum leptin level | F344/NSlc | male | 5.46 | ng/ml | specific pathogen-free condition (for 210 days) then fasting (for 1 days) then glucose solution, 2.8M (2 g/kg) | 67483 | specific pathogen-free condition (for 210 days) | fasting (for 1 days) | glucose solution, 2.8M (2 g/kg) |

6 | both adrenal glands weight to body weight ratio | F344/NSlc | male | 21.1 | mg/100g | specific pathogen-free condition | 71836 | specific pathogen-free condition | | |

8 | body weight | F344/NSlc | male | 412.03 | g | naive control condition | 98031 | naive control condition | | |

20 | body weight | F344/NSlc | male | 380.2 | g | naive control condition | 97718 | naive control condition | | |

6 | body weight | F344/NSlc | male | 233.2 | g | specific pathogen-free condition | 70731 | specific pathogen-free condition | | |

6 | body weight | F344/NSlc | male | 126.1 | g | specific pathogen-free condition | 70732 | specific pathogen-free condition | | |

6 | body weight | F344/NSlc | male | 80.8 | g | specific pathogen-free condition | 70733 | specific pathogen-free condition | | |

20 | body weight | F344/NSlc | male | 409.9 | g | fasting (between 16 and 18 hours) | 66179 | fasting (between 16 and 18 hours) | | |

9 | body weight | F344/NSlc | male | 387.4 | g | fasting (between 16 and 18 hours) | 66178 | fasting (between 16 and 18 hours) | | |

6 | plasma urea nitrogen level | F344/NSlc | male | 6.3189 | mmol/l | fasting (for 16 hours) | 77475 | fasting (for 16 hours) | | |

6 | plasma total protein level | F344/NSlc | male | 67 | mg/ml | fasting (for 16 hours) | 77466 | fasting (for 16 hours) | | |

6 | blood basophil count to total leukocyte count ratio | F344/NSlc | male | 0 | % | fasting (for 16 hours) | 77482 | fasting (for 16 hours) | | |

6 | plasma phosphate level | F344/NSlc | male | 7.9 | mg/dl | fasting (for 16 hours) | 77477 | fasting (for 16 hours) | | |

6 | activated partial thromboplastin time | F344/NSlc | male | 13.8 | s | fasting (for 16 hours) | 77462 | fasting (for 16 hours) | | |

6 | prothrombin time | F344/NSlc | male | 15.9 | s | fasting (for 16 hours) | 77461 | fasting (for 16 hours) | | |

6 | blood eosinophil count to total leukocyte count ratio | F344/NSlc | male | 0 | % | fasting (for 16 hours) | 77483 | fasting (for 16 hours) | | |

6 | blood lymphocyte count to total leukocyte count ratio | F344/NSlc | male | 83 | % | fasting (for 16 hours) | 77486 | fasting (for 16 hours) | | |

6 | blood monocyte count to total leukocyte count ratio | F344/NSlc | male | 0 | % | fasting (for 16 hours) | 77487 | fasting (for 16 hours) | | |

6 | total plasma calcium level | F344/NSlc | male | 10.5 | mg/dl | fasting (for 16 hours) | 77478 | fasting (for 16 hours) | | |

6 | plasma alkaline phosphatase activity level | F344/NSlc | male | 586 | IU/l | fasting (for 16 hours) | 77465 | fasting (for 16 hours) | | |

6 | urine chloride level | F344/NSlc | male | 162 | mEq/L | 0.9% sodium chloride solution (25 ml/kg) | 95002 | 0.9% sodium chloride solution (25 ml/kg) | | |

6 | urine potassium excretion rate to body weight ratio | F344/NSlc | male | 229 | uEq/100g/6 hrs | 0.9% sodium chloride solution (25 ml/kg) | 95001 | 0.9% sodium chloride solution (25 ml/kg) | | |

6 | urine chloride excretion rate to body weight ratio | F344/NSlc | male | 338 | uEq/100g/6 hrs | 0.9% sodium chloride solution (25 ml/kg) | 95003 | 0.9% sodium chloride solution (25 ml/kg) | | |

6 | red blood cell count | F344/NSlc | male | 0.952 | x 10E6 cells/ul | fasting (for 16 hours) | 77453 | fasting (for 16 hours) | | |

6 | white blood cell count | F344/NSlc | male | 6.1 | x 1000 cells/ul | fasting (for 16 hours) | 77459 | fasting (for 16 hours) | | |

6 | platelet count | F344/NSlc | male | 812 | x 1000 cells/ul | fasting (for 16 hours) | 77460 | fasting (for 16 hours) | | |

6 | total plasma bilirubin level | F344/NSlc | male | 0.01 | mg/dl | fasting (for 16 hours) | 77474 | fasting (for 16 hours) | | |

6 | plasma sodium level | F344/NSlc | male | 148.2 | mmol/l | fasting (for 16 hours) | 77479 | fasting (for 16 hours) | | |

6 | plasma potassium level | F344/NSlc | male | 3.87 | mmol/l | fasting (for 16 hours) | 77480 | fasting (for 16 hours) | | |

6 | plasma chloride level | F344/NSlc | male | 105 | mmol/l | fasting (for 16 hours) | 77481 | fasting (for 16 hours) | | |

6 | plasma aspartate aminotransferase activity level | F344/NSlc | male | 69 | U/l | fasting (for 16 hours) | 77463 | fasting (for 16 hours) | | |

6 | plasma alanine aminotransferase activity level | F344/NSlc | male | 42 | U/l | fasting (for 16 hours) | 77464 | fasting (for 16 hours) | | |

6 | urine potassium level | F344/NSlc | male | 109.5 | mmol/l | 0.9% sodium chloride solution (25 ml/kg) | 95000 | 0.9% sodium chloride solution (25 ml/kg) | | |

6 | urine sodium level | F344/NSlc | male | 123.4 | mmol/l | 0.9% sodium chloride solution (25 ml/kg) | 94998 | 0.9% sodium chloride solution (25 ml/kg) | | |

6 | timed urine volume | F344/NSlc | male | 19.68 | ml/d | 0.9% sodium chloride solution (25 ml/kg) | 94996 | 0.9% sodium chloride solution (25 ml/kg) | | |

6 | urine sodium excretion rate to body weight ratio | F344/NSlc | male | 0.007224 | uEq/min/g | 0.9% sodium chloride solution (25 ml/kg) | 94999 | 0.9% sodium chloride solution (25 ml/kg) | | |

6 | timed urine volume to body weight ratio | F344/NSlc | male | 0.0588 | ul/min/g | 0.9% sodium chloride solution (25 ml/kg) | 94997 | 0.9% sodium chloride solution (25 ml/kg) | | |

7 | adipocyte basal free fatty acid secretion | F344/NSlc | male | 0.44 | mEq/l | naive control condition | 97754 | naive control condition | | |

6 | blood segmented neutrophil count to total leukocyte count ratio | F344/NSlc | male | 17 | % | fasting (for 16 hours) | 77485 | fasting (for 16 hours) | | |

6 | plasma albumin to plasma total protein ratio | F344/NSlc | male | 1.42 | | fasting (for 16 hours) | 77468 | fasting (for 16 hours) | | |

6 | non-specified leukocyte count to total leukocyte count ratio | F344/NSlc | male | 0 | % | fasting (for 16 hours) | 77488 | fasting (for 16 hours) | | |

6 | blood band neutrophil count to total leukocyte count ratio | F344/NSlc | male | 0 | % | fasting (for 16 hours) | 77484 | fasting (for 16 hours) | | |

6 | heart weight to body weight ratio | F344/NSlc | male | 3.36 | g/kg | specific pathogen-free condition | 71828 | specific pathogen-free condition | | |